Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 15
Pharmacogenomics and Personalized Medicine
ISSN: 1178-7066
- View all (636)
- Volume 17, 2024 (15)
- Volume 16, 2023 (97)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Archive: Volume 15, 2022
Severe Vincristine-Induced Neuropathic Pain: A Case Report with Pharmacogenetic Analysis and Literature Review
Hu YH, Li GZ, Long JY, Yang QY, Zhang Y, Chen F, Wang YR
Pharmacogenomics and Personalized Medicine 2022, 15:1029-1035
Published Date: 30 December 2022
Clinical Characteristics and Gene Mutations of Two Families with MODY 3 in Inner Mongolia
Ren XY, Xue MR, Yan ZL, Zhang SJ, Liu M, Li AZ
Pharmacogenomics and Personalized Medicine 2022, 15:1019-1027
Published Date: 19 December 2022
AZGP1 Up-Regulation is a Potential Target for Andrographolide Reversing Radioresistance of Colorectal Cancer
Fang YY, Huang JM, Wen JY, Li JD, Shen JH, Zeng DT, Pan YF, Huang HQ, Huang ZG, Liu LM, Chen G
Pharmacogenomics and Personalized Medicine 2022, 15:999-1017
Published Date: 13 December 2022
Decreased Expression of a Novel lncRNA FAM181A-AS1 is Associated with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma
Liang W, Lu Y, Pan X, Zeng Y, Zheng W, Li Y, Nie Y, Li D, Wang D
Pharmacogenomics and Personalized Medicine 2022, 15:985-998
Published Date: 2 December 2022
Germline PRDM1 Variant rs2185379 in Long-Term Recurrence-Free Survivors of Advanced Ovarian Cancer
Mitamura T, Zhai T, Hatanaka KC, Hatanaka Y, Amano T, Wang L, Tanaka S, Watari H
Pharmacogenomics and Personalized Medicine 2022, 15:977-984
Published Date: 29 November 2022
Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database
Wittwer NL, Meier CR, Huber CA, Meyer zu Schwabedissen HE, Allemann S, Schneider C
Pharmacogenomics and Personalized Medicine 2022, 15:967-976
Published Date: 23 November 2022
Next-Generation Sequencing and Bioinformatics-Based Protocol for the Full-Length CYP2E1 Gene Polymorphism Analysis
Igumnova V, Kivrane A, Viksna A, Norvaisa I, Ranka R
Pharmacogenomics and Personalized Medicine 2022, 15:959-965
Published Date: 8 November 2022
CES1 and SLC6A2 Genetic Variants As Predictors of Response To Methylphenidate in Autism Spectrum Disorders
Hernandez MH, Bote V, Serra-LLovich A, Cendros M, Salazar J, Mestres C, Guijarro S, Alvarez A, Lamborena C, Mendez I, Sanchez B, Hervas A, Arranz MJ
Pharmacogenomics and Personalized Medicine 2022, 15:951-957
Published Date: 8 November 2022
Utilizing Pharmacogenomics Results to Determine Opioid Appropriateness and Improve Pain Management in a Patient with Osteoarthritis
Pizzolato K, Thacker D, Del Toro-Pagán NM, Amin NS, Hanna A, Turgeon J, Michaud V
Pharmacogenomics and Personalized Medicine 2022, 15:943-950
Published Date: 7 November 2022
What Personalized Medicine Humans Need and Way to It ——also on the Practical Significance and Scientific Limitations of Precision Medicine
Yuan B
Pharmacogenomics and Personalized Medicine 2022, 15:927-942
Published Date: 2 November 2022
The Role of Single Nucleotide Polymorphisms in Transporter Proteins and the Folate Metabolism Pathway in Delayed Methotrexate Excretion: A Case Report and Literature Review
Wang J, Zhao YT, Sun MJ, Chen F, Guo HL
Pharmacogenomics and Personalized Medicine 2022, 15:919-926
Published Date: 2 November 2022
Mowat-Wilson Syndrome as a Differential Diagnosis in Patients with Congenital Heart Defects and Dysmorphic Facies
Pachajoa H, Gomez-Pineda E, Giraldo-Ocampo S, Lores J
Pharmacogenomics and Personalized Medicine 2022, 15:913-918
Published Date: 1 November 2022
Drug–Drug–Gene Interactions in Cardiovascular Medicine
Asiimwe IG, Pirmohamed M
Pharmacogenomics and Personalized Medicine 2022, 15:879-911
Published Date: 2 November 2022
Neurofibromatosis Type 1 and Hypospadias in a Male 46, XY with a Mutation in the NF1 Gene and a Mutation in NR5A1
Perafan-Valdes L, Giraldo-Ocampo S, Lores J, Pachajoa H
Pharmacogenomics and Personalized Medicine 2022, 15:873-878
Published Date: 25 October 2022
Shwachman Diamond Syndrome with Arrhythmia as the First Manifestation a Case Report and Literature Review
Yu H, Zhao W, Ni Y, Li L
Pharmacogenomics and Personalized Medicine 2022, 15:867-872
Published Date: 11 October 2022
Downregulation of Crystallin Lambda 1 is a New Independent Prognostic Marker in Clear Cell Renal Cell Carcinoma
Feng L, Ding G, Zhou Y, Zhu H, Jiang H
Pharmacogenomics and Personalized Medicine 2022, 15:857-866
Published Date: 10 October 2022
Association of CYP7A1 and CYP2E1 Polymorphisms with Type 2 Diabetes in the Chinese Han Populations
Zhang L, Tang J, Wang Y, Wang X, Wang F
Pharmacogenomics and Personalized Medicine 2022, 15:843-855
Published Date: 21 September 2022
Contribution of ZBTB20 Polymorphisms to Esophageal Cancer Risk Among the Chinese Han Population
Yu S, Yuan G, Hu F, Li Y, Chen Z, Zhang R, Li P, Chen Z, Song J
Pharmacogenomics and Personalized Medicine 2022, 15:827-842
Published Date: 20 September 2022
The Association Between Genetic Polymorphisms of Transporter Genes and Prognosis of Platinum-Based Chemotherapy in Lung Cancer Patients
He J, Wang Z, Zou T, Wang Y, Li XP, Chen J
Pharmacogenomics and Personalized Medicine 2022, 15:817-825
Published Date: 14 September 2022
IL-10 rs1800896 Polymorphism: A Risk Factor for Adult Acute Lymphoblastic Leukemia
Abdalhabib EK, Alzahrani B, Saboor M, Hamza A, Elfaki EM, Alanazi F, Alenazy FO, Algarni A, Khider Ibrahim I, Mohamed HA, Hussein Alfeel A, Ali Alshaikh N
Pharmacogenomics and Personalized Medicine 2022, 15:809-815
Published Date: 12 September 2022
PFKP and GPC6 Variants Were Correlated with Alcohol-Induced Femoral Head Necrosis Risk in the Chinese Han Population
Liu C, Liu X, Li X
Pharmacogenomics and Personalized Medicine 2022, 15:797-808
Published Date: 9 September 2022
Expression Profile and Bioinformatics Analysis of Circular RNAs in Patients with Vitiligo
Zhang R, Hou Z, Liao K, Yu C, Jing R, Tu C
Pharmacogenomics and Personalized Medicine 2022, 15:785-796
Published Date: 3 September 2022
Risk Factors and Predictive Model for Dermatomyositis Associated with Rapidly Progressive Interstitial Lung Disease
Wang K, Tian Y, Liu S, Zhang Z, Shen L, Meng D, Li J
Pharmacogenomics and Personalized Medicine 2022, 15:775-783
Published Date: 1 September 2022
Prescription Advice Based on Data of Drug-Drug-Gene Interaction of Patients with Polypharmacy
Salamone S, Spirito S, Simmaco M, Unger M, Preissner S, Gohlke BO, Eckert A, Preissner R
Pharmacogenomics and Personalized Medicine 2022, 15:765-773
Published Date: 18 August 2022
Genome-Wide Association Study on the Hematological Phenotypic Characteristics of the Han Population from Northwest China
Yang W, He X, Yao Y, Lu H, Wang Y, Zhang Z, Wang Y, Wang L, He Y, Yuan D, Jin T
Pharmacogenomics and Personalized Medicine 2022, 15:743-763
Published Date: 3 August 2022
Cuproptosis-Related Gene – SLC31A1, FDX1 and ATP7B – Polymorphisms are Associated with Risk of Lung Cancer
Yun Y, Wang Y, Yang E, Jing X
Pharmacogenomics and Personalized Medicine 2022, 15:733-742
Published Date: 26 July 2022
A Study on the Molecular Mechanism of High Altitude Heart Disease in Children
Tashi QZ, Tsering SB, Zhou NN, Zhang Y, Huang YJ, Jia J, Li TJ
Pharmacogenomics and Personalized Medicine 2022, 15:721-731
Published Date: 21 July 2022
Multiple Recurrent Copy Number Variations (CNVs) in Chromosome 22 Including 22q11.2 Associated with Autism Spectrum Disorder
Alhazmi S, Alzahrani M, Farsi R, Alharbi M, Algothmi K, Alburae N, Ganash M, Azhari S, Basingab F, Almuhammadi A, Alqosaibi A, Alkhatabi H, Elaimi A, Jan M, Aldhalaan HM, Alrafiah A, Alrofaidi A
Pharmacogenomics and Personalized Medicine 2022, 15:705-720
Published Date: 20 July 2022
Identification of a Novel OFD1 Variant in a Patient with Primary Ciliary Dyskinesia
Yang B, Lei C, Yang D, Lu C, Xu Y, Wang L, Guo T, Wang R, Luo H
Pharmacogenomics and Personalized Medicine 2022, 15:697-704
Published Date: 11 July 2022
The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review
Yalçin N, Flint RB, van Schaik RHN, Simons SHP, Allegaert K
Pharmacogenomics and Personalized Medicine 2022, 15:675-696
Published Date: 30 June 2022
Impact of HOXB4 and PRDM16 Gene Expressions on Prognosis and Treatment Response in Acute Myeloid Leukemia Patients
El-Meligui YM, Hassan NM, Kassem AB, Gouda NA, Mohanad M, Hamouda MA, Salahuddin A
Pharmacogenomics and Personalized Medicine 2022, 15:663-674
Published Date: 25 June 2022
Effect of Apolipoprotein E ϵ4 Allele on the Progression of Carotid Atherosclerosis Through Apolipoprotein Levels
Ma W, Zhang L, Luo L, Zhang S, Yang S, Yao H, Zhang L, Lu X, Feng W
Pharmacogenomics and Personalized Medicine 2022, 15:653-661
Published Date: 21 June 2022
Pharmacogenetics of Breast Cancer Treatments: A Sub-Saharan Africa Perspective
Nthontho KC, Ndlovu AK, Sharma K, Kasvosve I, Hertz DL, Paganotti GM
Pharmacogenomics and Personalized Medicine 2022, 15:613-652
Published Date: 21 June 2022
Inducible Nitric Oxide Synthase iNOS-954-G>C and Ex16+14-C>T Gene Polymorphisms and Susceptibility to Vitiligo in the Saudi Population
Al-Harthi F, Huraib GB, Mustafa M, Al-Qubaisy Y, Al-Nomair N, Abdurrahman N, Al-Asmari A
Pharmacogenomics and Personalized Medicine 2022, 15:603-612
Published Date: 13 June 2022
Examining an Association of Single Nucleotide Polymorphisms with Hyperuricemia in Chinese Flight Attendants
Ye J, Zeng Z, Chen Y, Wu Z, Yang Q, Sun T
Pharmacogenomics and Personalized Medicine 2022, 15:589-602
Published Date: 8 June 2022
Compound Heterozygous Mutations in TGM1 Causing a Severe Form of Lamellar Ichthyosis: A Case Report
Zeng J, Shan B, Guo L, Lv S, Li F
Pharmacogenomics and Personalized Medicine 2022, 15:583-588
Published Date: 7 June 2022
Effective Treatment of Low-Grade Myofibroblastic Sarcoma with Apatinib: A Case Report and Literature Review
Lin Y, Gao X, Liu Z, Liu Z, Li Y, Liang R, Liao Z, Ye J
Pharmacogenomics and Personalized Medicine 2022, 15:573-582
Published Date: 7 June 2022
Effect of Genetic Variations in Drug-Metabolizing Enzymes and Drug Transporters on the Pharmacokinetics of Rifamycins: A Systematic Review
Sileshi T, Mekonen G, Makonnen E, Aklillu E
Pharmacogenomics and Personalized Medicine 2022, 15:561-571
Published Date: 4 June 2022
Gene Polymorphisms of m6A Erasers FTO and ALKBH1 Associated with Susceptibility to Gastric Cancer
Li Y, Zhou D, Liu Q, Zhu W, Ye Z, He C
Pharmacogenomics and Personalized Medicine 2022, 15:547-559
Published Date: 31 May 2022
Cancer Metastases from Lung Adenocarcinoma Disappeared After Molecular Targeted Therapy: A Successfully Clinical Treatment Experience
Li MJ, Wei J, Ai GP, Liu Y, Zhu J
Pharmacogenomics and Personalized Medicine 2022, 15:539-546
Published Date: 26 May 2022
An Integrative Analysis Identifying RAB40C as an Oncogenic Immune Protein and Prognostic Marker of Lung Squamous Cell Carcinoma
Wu H, Dong X, Liao L, Huang L
Pharmacogenomics and Personalized Medicine 2022, 15:525-537
Published Date: 22 May 2022
Psoriasis Patients with Specific HLA-Cw Alleles and Lower Plasma IL-17 Level Show Improved Response to Topical Lindioil Treatment
Lin YK, Wang CY, Huang YH, Chang YC, Chen CB, Wang CW, Hui RCY, Chung WH
Pharmacogenomics and Personalized Medicine 2022, 15:515-524
Published Date: 13 May 2022
Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran
Di Stefano V, Fava A, Gentile L, Guaraldi P, Leonardi L, Poli L, Tagliapietra M, Vastola M, Fanara S, Ferrero B, Giorgi M, Perfetto F, Russo M, Russo D
Pharmacogenomics and Personalized Medicine 2022, 15:499-514
Published Date: 12 May 2022
Genetic Variations of CARMN Modulate Glioma Susceptibility and Prognosis in a Chinese Han Population
Xi M, Zhang G, Wang L, Chen H, Gao L, Zhang L, Yang Z, Shi H
Pharmacogenomics and Personalized Medicine 2022, 15:487-497
Published Date: 11 May 2022
Correlation Between Angiotensin Receptor Type 1 Polymorphisms and Atherosclerotic Cerebral Infarction Risk
Chen L, Wang Y, Wang Y, Huang S, Wu Z, He J, Zhong W, Zhao B, Ma G, Li Y
Pharmacogenomics and Personalized Medicine 2022, 15:477-485
Published Date: 11 May 2022
Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report
Jeiziner C, Allemann SS, Hersberger KE, Meyer zu Schwabedissen HE
Pharmacogenomics and Personalized Medicine 2022, 15:465-475
Published Date: 9 May 2022
Missense Variant rs28362680 in BTNL2 Reduces Risk of Coronary Heart Disease
Zhuo J, Wu Y, Li W, Li Z, Ding Y, Jin T
Pharmacogenomics and Personalized Medicine 2022, 15:449-464
Published Date: 6 May 2022
Susceptibility of Genetic Variations in Methylation Pathway to Gastric Cancer
Xiong M, Pan B, Wang X, Nie J, Pan Y, Sun H, Xu T, Cho WCS, Wang S, He B
Pharmacogenomics and Personalized Medicine 2022, 15:441-448
Published Date: 4 May 2022
Knowledge, Attitudes and Practices of Pharmacogenomics Among Senior Pharmacy Students: A Cross Sectional Study from Punjab, Pakistan
Shah S, Hanif M, Khan HU, Khan FU, Abbas G, Khurram H, Khames A, Abdelgawad MA, Said AS, Abourehab MAS, Maheen S, Chand UR, Haris M
Pharmacogenomics and Personalized Medicine 2022, 15:429-439
Published Date: 25 April 2022
The Efficacy of a Didactic and Case-Based Pharmacogenomics Education Program on Improving the Knowledge and Confidence of Alberta Pharmacists
Hayashi M, Mahmoud SH, Hamdy DA
Pharmacogenomics and Personalized Medicine 2022, 15:409-427
Published Date: 23 April 2022
Therapeutic Management of Patients with FLT3 + Acute Myeloid Leukemia: Case Reports and Focus on Gilteritinib Monotherapy
Bocchia M, Carella AM, Mulè A, Rizzo L, Turrini M, Abbenante MC, Cairoli R, Calafiore V, Defina M, Gardellini A, Luzi G, Patti C, Pinazzi MB, Riva M, Rossi G, Sammartano V, Rigacci L
Pharmacogenomics and Personalized Medicine 2022, 15:393-407
Published Date: 22 April 2022
Identification of NFASC and CHL1 as Two Novel Hub Genes in Endometriosis Using Integrated Bioinformatic Analysis and Experimental Verification
Chen P, Yao M, Fang T, Ye C, Du Y, Jin Y, Wu R
Pharmacogenomics and Personalized Medicine 2022, 15:377-392
Published Date: 22 April 2022
Association of Long Non-Coding RNAs (lncRNAs) ANRIL and MALAT1 Polymorphism with Cervical Cancer
Yao Y, Liang Y, Dong X, Liu S, Zhang S, Liu W, Li Y, Shi L, Yan Z, Yao Y
Pharmacogenomics and Personalized Medicine 2022, 15:359-375
Published Date: 21 April 2022
Association of IL-6 and TGF-β Gene Polymorphisms with the Risk of Thoracolumbar Osteoporotic Vertebral Compression Fractures
Xiong Y, He Y, Peng Y, Geng Y
Pharmacogenomics and Personalized Medicine 2022, 15:351-358
Published Date: 19 April 2022
Novel Compound Heterozygous Variants in CCDC40 Associated with Primary Ciliary Dyskinesia and Multiple Morphological Abnormalities of the Sperm Flagella
Xu Y, Yang B, Lei C, Yang D, Ding S, Lu C, Wang L, Guo T, Wang R, Luo H
Pharmacogenomics and Personalized Medicine 2022, 15:341-350
Published Date: 15 April 2022
Associations Between Genetic Polymorphisms Within Transporter Genes and Clinical Response to Methotrexate in Chinese Rheumatoid Arthritis Patients: A Pilot Study
Cen H, Wen QW, Zhang HQ, Yu H, Zeng Z, Jin T, Wang TH, Qin W, Huang H, Wu XD
Pharmacogenomics and Personalized Medicine 2022, 15:327-339
Published Date: 12 April 2022
The Impact of BCL11A Polymorphisms on Endometrial Cancer Risk Among Chinese Han Females
Cai J, Peng S, Wang H, Bao S
Pharmacogenomics and Personalized Medicine 2022, 15:311-325
Published Date: 7 April 2022
ABCA7 rs3764650 Polymorphism is Associated with Delayed Neurocognitive Recovery
Yu L, Ji H, Zhou M, Guo Y, Liu J, Lei D, Han C, Ma T
Pharmacogenomics and Personalized Medicine 2022, 15:301-309
Published Date: 30 March 2022
Acyl-CoA Binding Domain Containing 4 Polymorphism rs4986172 and Expression Can Serve as Overall Survival Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Hepatectomy
Huang H, Liao X, Zhu G, Han C, Wang X, Yang C, Zhou X, Liang T, Huang K, Peng T
Pharmacogenomics and Personalized Medicine 2022, 15:277-300
Published Date: 29 March 2022
DNTTIP2 Expression is Associated with Macrophage Infiltration and Malignant Characteristics in Low-Grade Glioma
Liu YJ, Zeng SH, Qian WH, Tao MX, Zhu YY, Li JP
Pharmacogenomics and Personalized Medicine 2022, 15:261-275
Published Date: 24 March 2022
Chromosomal Region 11p14.1 is Associated with Pharmacokinetics and Pharmacodynamics of Bisoprolol
Fontana V, Turner RM, Francis B, Yin P, Pütz B, Hiltunen TP, Ruotsalainen S, Kontula KK, Müller-Myhsok B, Pirmohamed M
Pharmacogenomics and Personalized Medicine 2022, 15:249-260
Published Date: 22 March 2022
The Single Nucleotide Polymorphisms of AP1S1 are Associated with Risk of Esophageal Squamous Cell Carcinoma in Chinese Population
Su F, Fang Y, Yu J, Jiang T, Lin S, Zhang S, Lv L, Long T, Pan H, Qi J, Zhou Q, Tang W, Ding G, Wang L, Tan L, Yin J
Pharmacogenomics and Personalized Medicine 2022, 15:235-247
Published Date: 17 March 2022
Increased Risk of Acute Lymphoblastic Leukemia in Adult Patients with GSTM1 Null Genetic Polymorphism
Abdalhabib EK, Alzahrani B, Alanazi F, Algarni A, Ibrahim IK, Mohamed HA, Hamali HA, Mobarki AA, Dobie G, Saboor M
Pharmacogenomics and Personalized Medicine 2022, 15:227-234
Published Date: 15 March 2022
Value of UGT2B7-161 Single Nucleotide Polymorphism in Predicting the Risk of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Who Underwent Pertuzumab Combined with Trastuzumab Therapy by PSL
Li J, Luo H, Liu YY, Chen LX, Zhu MQ, Deng QT, Zhu DM, Wang ZM, Xu JF
Pharmacogenomics and Personalized Medicine 2022, 15:215-225
Published Date: 15 March 2022
Association Between Selected Single Nucleotide Polymorphisms in Globin and Related Genes and Response to Hydroxyurea Therapy in Ghanaian Children with Sickle Cell Disease
Manu GP, Segbefia C, N'guessan BB, Coffie SA, Adjei GO
Pharmacogenomics and Personalized Medicine 2022, 15:205-214
Published Date: 10 March 2022
Drug Resistance to HIV-1 Integrase Inhibitors Among Treatment-Naive Patients in Beijing, China
Yu F, Li Q, Wang L, Zhao H, Wu H, Yang S, Tang Y, Xiao J, Zhang F
Pharmacogenomics and Personalized Medicine 2022, 15:195-203
Published Date: 10 March 2022
MicroRNA Dysregulation in Prostate Cancer
Schitcu VH, Raduly L, Nutu A, Zanoaga O, Ciocan C, Munteanu VC, Cojocneanu R, Petrut B, Coman I, Braicu C, Berindan-Neagoe I
Pharmacogenomics and Personalized Medicine 2022, 15:177-193
Published Date: 10 March 2022
Associations of SMAD4 rs10502913 and NLRP3 rs1539019 Polymorphisms with Risk of Coal Workers’ Pneumoconiosis Susceptibility in Chinese Han Population
Zhao H, Huang Y, Wang H, Zhao J, Tian S, Bai H, Guo M, Dong C, Shi Y, Li X, Zhu C, Feng T, Ma X, Hou Z
Pharmacogenomics and Personalized Medicine 2022, 15:167-175
Published Date: 4 March 2022
Ferroptosis-Related APOE, BCL3 and ALOX5AP Gene Polymorphisms are Associated with the Risk of Thyroid Cancer
Xiao Z, Zhao H
Pharmacogenomics and Personalized Medicine 2022, 15:157-165
Published Date: 25 February 2022
Prediction of Tacrolimus Dose/Weight-Adjusted Trough Concentration in Pediatric Refractory Nephrotic Syndrome: A Machine Learning Approach
Mo X, Chen X, Wang X, Zhong X, Liang H, Wei Y, Deng H, Hu R, Zhang T, Chen Y, Gao X, Huang M, Li J
Pharmacogenomics and Personalized Medicine 2022, 15:143-155
Published Date: 22 February 2022
DNA Methylation Level of Transcription Factor Binding Site in the Promoter Region of Acyl-CoA Synthetase Family Member 3 (ACSF3) in Saudi Autistic Children
Algothmi K, Alqurashi A, Alrofaidi A, Alharbi M, Farsi R, Alburae N, Ganash M, Azhari S, Basingab F, Almuhammadi A, Alqosaibi A, Alkhatabi H, Elaimi A, Jan M, Aldhalaan H, Alrafiah A, Alhazmi S
Pharmacogenomics and Personalized Medicine 2022, 15:131-142
Published Date: 18 February 2022
Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia
Vanwong N, Tipnoppanon S, Na Nakorn C, Srisawasdi P, Rodcharoen P, Medhasi S, Chariyavilaskul P, Siwamogsatham S, Vorasettakarnkij Y, Sukasem C
Pharmacogenomics and Personalized Medicine 2022, 15:119-130
Published Date: 17 February 2022
GABRA1 and GABRB2 Polymorphisms are Associated with Propofol Susceptibility
Zeng Y, Cao S, Chen M, Fang C, Ouyang W
Pharmacogenomics and Personalized Medicine 2022, 15:105-117
Published Date: 9 February 2022
Precision Medicine Based on CFTR Genotype for People with Cystic Fibrosis
Haq I, Almulhem M, Soars S, Poulton D, Brodlie M
Pharmacogenomics and Personalized Medicine 2022, 15:91-104
Published Date: 5 February 2022
Clopidogrel Use and CYP2C19 Genotypes in Patients Undergoing Vascular Intervention Procedure: A Hospital-Based Study
Liao YJ, Hsiao TH, Lin CH, Hsu CS, Chang YL, Chen YW, Hsu CY, Chen YM, Wu MF
Pharmacogenomics and Personalized Medicine 2022, 15:81-89
Published Date: 2 February 2022
The Effect of SOCS2 Polymorphisms on Type 2 Diabetes Mellitus Susceptibility and Diabetic Complications in the Chinese Han Population
Pan J, Tong R, Deng Q, Tian Y, Wang N, Peng Y, Fei S, Zhang W, Cui J, Guo C, Yao J, Wei C, Xu J
Pharmacogenomics and Personalized Medicine 2022, 15:65-79
Published Date: 29 January 2022
An Analysis of the Pathogenic Genes and Mutation Sites of Macrodactyly
Li JF, Tian GL, Pan H, Zhang WT, Li DC, Liu JD, Zhao L, Li HL
Pharmacogenomics and Personalized Medicine 2022, 15:55-64
Published Date: 29 January 2022
The Cyp2b6 Gene Polymorphism and Phenotypic Correlation of Efavirenz-Based Combination Therapy Among the Niger Delta Ethnic Population: Implications in Modern Pharmacogenomics
Bunu JS, Azibanasamesa DC Owaba, Vaikosen EN, Ebeshi BU
Pharmacogenomics and Personalized Medicine 2022, 15:45-54
Published Date: 25 January 2022
Identification of Potential Biological Factors Affecting the Treatment of Ticagrelor After Percutaneous Coronary Intervention in the Chinese Population
Yuan D, Shi X, Gao L, Wan G, Zhang H, Yang Y, Zhao Y, Sun D
Pharmacogenomics and Personalized Medicine 2022, 15:29-43
Published Date: 20 January 2022
Genetic and Psychosocial Risk Factors Associated with Suicide Among Community Veterans: Implications for Screening, Treatment and Precision Medicine
Boscarino JA, Adams RE, Urosevich TG, Hoffman SN, Kirchner HL, Chu X, Shi W, Boscarino JJ, Dugan RJ, Withey CA, Figley CR
Pharmacogenomics and Personalized Medicine 2022, 15:17-27
Published Date: 14 January 2022
Association Between SNPs in the One-Carbon Metabolism Pathway and the Risk of Female Breast Cancer in a Chinese Population
Wang X, Xiong M, Pan B, Cho WC, Zhou J, Wang S, He B
Pharmacogenomics and Personalized Medicine 2022, 15:9-16
Published Date: 11 January 2022
A Novel Missense Mutation in TWNK Gene Causing Perrault Syndrome Type 5 in a Chinese Family and Review of the Literature
Wei L, Hou L, Ying YQ, Luo XP
Pharmacogenomics and Personalized Medicine 2022, 15:1-8
Published Date: 8 January 2022